Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.35
-0.27 (-3.13%)
Sep 3, 2026, 4:00 PM EDT - Market closed
Kyverna Therapeutics Employees
Kyverna Therapeutics had 149 employees as of June 30, 2026. The number of employees increased by 20 or 15.50% compared to the same quarter last year.
Employees
149
Change
20
Growth
15.50%
Revenue / Employee
n/a
Profits / Employee
-$1,024,416
Market Cap
516.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 149 | 20 | 15.50% |
| Mar 31, 2026 | 129 | 10 | 8.40% |
| Dec 31, 2025 | 130 | 18 | 16.07% |
| Sep 30, 2025 | 129 | 10 | 8.40% |
| Jun 30, 2025 | 129 | 17 | 15.18% |
| Mar 31, 2025 | 119 | 19 | 19.00% |
| Dec 31, 2024 | 112 | 16 | 16.67% |
| Sep 30, 2024 | 119 | 30 | 33.71% |
| Jun 30, 2024 | 112 | 23 | 25.84% |
| Mar 31, 2024 | 100 | - | - |
| Dec 31, 2023 | 96 | - | - |
| Sep 30, 2023 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Capricor Therapeutics | 231 |
| ProKidney | 231 |
| ARS Pharmaceuticals | 200 |
| Puma Biotechnology | 179 |
| Artiva Biotherapeutics | 115 |
| Prelude Therapeutics | 79 |
| Prothena Corporation | 67 |
| Eupraxia Pharmaceuticals | 49 |
KYTX News
- 1 day ago - Kyverna Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 23 days ago - Kyverna Therapeutics reports Q2 EPS (63c), consensus (68c) - TheFly
- 23 days ago - Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results - GlobeNewsWire
- 23 days ago - Kyverna Therapeutics Earnings release: Q2 2026 - Filings
- 23 days ago - Kyverna Therapeutics Quarterly report: Q2 2026 - Filings
- 23 days ago - Kyverna Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Kyverna Therapeutics, ElevateBio announce miv-cel manufacturing agreement - TheFly
- 5 weeks ago - Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel - GlobeNewsWire